Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07526558) titled 'Mast Cell Treatment in Post-tick Bite Illness (PTBI)' on April 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: University of North Carolina, Chapel Hill
Condition:
Post-tick Bite Illness
Mast Cell Stabilizer
Intervention:
Drug: Ketotifen
Drug: fexofenadine
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: April 30, 2026
Target Sample Size: 50
Countries of Recruitment:
United States
To know ...